540729 — Vanta Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹131.04m
- IN₹744.74m
- IN₹97.23m
Annual cashflow statement for Vanta Bioscience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 13.4 | 5.89 | 2.28 | -103 | -88.3 |
| Depreciation | |||||
| Non-Cash Items | 19.5 | 21.2 | 23.5 | 58.9 | 57.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -23.7 | 29.1 | 13.3 | 10.8 | 13.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 21.1 | 68.7 | 52.2 | -6.28 | 26.8 |
| Capital Expenditures | -73.5 | -222 | -172 | -287 | -34 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | — | 228 | 0.915 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -73.5 | -222 | -172 | -59.1 | -33.1 |
| Financing Cash Flow Items | -19.5 | -21.4 | -23.5 | -58.9 | -57.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 21.7 | 178 | 95.3 | 64.1 | 6.93 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -30.7 | 24.6 | -24.3 | -1.28 | 0.64 |